Recombinant antibody production at evitria

evitria is your expert when it comes to the custom production of recombinant antibodies for research, industrial and small-scale applications.

We are specialized in transient antibody production in CHO cells. This allows us to produce immunoglobulins with high batch-to-batch consistency, low endotoxin levels and at high speed.

We believe that high-quality antibodies pay off at every stage of your project.

Our recombinant antibody expression services include:

  • Recombinant antibodies
  • Afucosylated antibodies
  • Fc-silenced antibodies
  • Bispecific antibodies
  • Other recombinant proteins
recombinant antibody
0 >

Antibody production runs

0 >

Antibodies purified

0 > %

Projects completed on time

0 < weeks

From Sequence to Antibody

Recombinant antibody production services

evitria AG has a single focus on the expression of recombinant antibodies since its foundation in 2010 and is one of the leading service providers in this field.

Having performed more than 120,000 production runs, expressed more than 23,000 proteins and purified more than 20,000 antibodies since 2010, we have been providing our products to customers around the globe – from academic laboratories and small biotech start-ups to global biopharma companies.

Overview:

  • custom design for your individual needs
  • independent of laboratory animals
  • no animal contamination
  • from sequence to antibody in 5 weeks
  • high yields, large-scale production

Contact us

    How to choose a partner for custom antibody production?

    Our expertise in recombinant antibody expression

    Our CHO-based expression platform allows us flexible scalability to supply companies in discovery research and commercial manufacturing. Recombinant formats support batch-to-batch consistency. With CHO cell antibody production, we are able to offer recombinant antibodies in large scales with very low levels of endotoxins (<1 EU/mg).

    Furthermore, expression in CHO cells can be much faster than in comparable cell lines. From sequence to antibody within 5 weeks is our goal, which we can meet in 99% of all projects.

    When choosing evitria as your provider of recombinant antibody production services, you profit from our profound expertise in fields like

    • Isotype switching
    • Chimerization
    • Glyco-engineering
    • Bispecific and trispecific antibodies
    • Fusion antibodies including Fc fusion proteins

    Our Process

    Our efficient workflow in antibody production allows us to provide you with high quality antibodies within 5 weeks from sequence to shipment.

    From sequence to antibody in 5 weeks

    project start - how we work at evitria

    Project start

    0-1 business days

    pilot study (from electronic sequence to quantified pilot supernatant)

    Pilot study

    (from electronic sequence to quantified pilot supernatant)

    15-20 business days

    larger-scale expression - how we work at evitria

    Larger-scale expression

    5-10 business days

    purification - how we work at evitria

    Purification

    2-3 business days

    final analytics - how we work at evitria

    Final analytics

    2-3 business days

    shipment - how we work at evitria

    Shipment

    1-2 business days

    Recommended Downloads

    Antibody development and quality control by mass spectometry

      Frequently asked questions

      No, evitria does not use live animals for antibody production, and neither are E. Coli or HEK cells used. Instead, we rely on CHO cells as a mammalian expression system, as this comes with several advantages.

      Protein A purification is standard and, as needed, we use alternative resins such as Protein G, L, Kappa/Lambda-Select or anti-IgG-CH1. An additional size exclusion chromatography (SEC) purification step can be added. Please contact us for more details.

      For new antibodies, our average timeline is between 6 and 7 weeks. With our standard services, we do guarantee 6-8 weeks from amino acid sequence to purified antibody and 5-6 weeks with our RUSH offering. If we have produced the antibody before, reproduction will take 1-2 weeks.

      Recombinant antibody expression involves the artificial creation of monoclonal antibodies through genetic engineering and related methods. Genetically engineered antibodies hold significant value in scientific research due to their capability to identify specific antigenic sites on various molecules, such as drugs, hormones, microbial antigens, and cell receptors.

      Get in Touch

        Subscribe to the evitria newsletter and stay up to date